Which adverse effect is listed for evinacumab?

Enhance your knowledge of antihyperlipidemics and lipid management. Study with multiple choice questions and detailed explanations. Ace your test!

Multiple Choice

Which adverse effect is listed for evinacumab?

Evinacumab, given by IV infusion, has nasopharyngitis listed among its common adverse events in labeling and trial reports. This reflects the types of upper respiratory tract symptoms that nonspecifically occur with monoclonal antibody therapies administered systemically. Injection site reactions are unlikely with an IV infusion, and while fatigue or dizziness can occur with many drugs, nasopharyngitis is the adverse effect specifically recognized for evinacumab, making it the best choice.

Evinacumab, given by IV infusion, has nasopharyngitis listed among its common adverse events in labeling and trial reports. This reflects the types of upper respiratory tract symptoms that nonspecifically occur with monoclonal antibody therapies administered systemically. Injection site reactions are unlikely with an IV infusion, and while fatigue or dizziness can occur with many drugs, nasopharyngitis is the adverse effect specifically recognized for evinacumab, making it the best choice.

More practice questions